QSS
SCLN

Quantitative Systematic Strategies’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Quantitative Systematic Strategies’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-15,612
Closed -$152K – 587
2016
Q1 		$152K Buy
+15,612
New +$139K 0.06% 327

Other funds holding SCLN

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Quantitative Systematic Strategies's SCLN Position: Q2 2016 in Review

Quantitative Systematic Strategies sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q2 2016, closing a stake of 15,612 shares — an estimated $152K sold.

Quantitative Systematic Strategies first reported a position in SCLN in Q1 2016 and held it in 1 quarter. The position peaked at $152K in Q1 2016. 151 funds tracked by Wall St. Rank hold SCLN as of Q2 2016.

  • Quantitative Systematic Strategies reported no remaining Sciclone Pharmaceuticals Inc position as of Q2 2016 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 15,612 Sciclone Pharmaceuticals Inc shares in Q2 2016, an estimated $152K.
  • Quantitative Systematic Strategies first reported a position in Sciclone Pharmaceuticals Inc in Q1 2016 and held it in 1 quarter.
  • Quantitative Systematic Strategies's Sciclone Pharmaceuticals Inc position peaked at $152K in Q1 2016.
  • 151 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q2 2016.

Based on Quantitative Systematic Strategies's 13F filing for Q2 2016, filed 28 Jul 2016.